FDA reviews adverse events, durability of Inspire Medical's sleep apnea implant

Inspire Medical's Inspire II Upper Airway Stimulator heads to the FDA tomorrow, when an expert panel will consider admitting the device to the U.S. market.

Minnesota-based Inspire Medical Systems has a date with the FDA tomorrow, when the agency's expert Anesthesiology & Respiratory Therapy Devices Panel will review data and make a recommendation on the Inspire II Upper Airway Stimulator.

Food & Drug Administration (FDA), Inspire Medical Systems Inc.

News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Minnesota, Neuromodulation/Neurostimulation, Pre-Market Approval (PMA), Sleep Monitoring/Sleep Apnea

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1e7QLl1